MST1 and gastric cancer: A recent study suggested that other drugs with similar mechanisms of action can reactivate the Hippo pathway, thereby inhibiting gastric cancer and enhancing chemotherapy sensitivity (105).MST1/2 activation drugs not only effectively inhibit the progression of gastric cancer but are also capable of significantly suppressing the metastasis of colorectal cancer.